您好!博飞美科试剂欢迎您! 400-608-7598

(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑,98%

[3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
厂家直销
博飞美科提供的所有产品仅用于科研等非医疗用途,非药品不可食用,不可用于人体或动物的临床诊断和治疗,我们不为个人提供产品及服务。如您需要产品COA等资料,可至下方“质量控制”中下载
PA78895
PERFEMIKER
180186-94-1
C21H18N2O2
330.38
品牌 货号 包装 纯度 目录价 会员价 库存 数量 购买车
PERFEMIKER PA78895-100mg 100mg 98% ¥144.00 登录可见优惠价格
PERFEMIKER PA78895-250mg 250mg 98% ¥257.00 登录可见优惠价格
PERFEMIKER PA78895-1g 1g 98% ¥691.00 登录可见优惠价格
产品名称: (+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑,98%
中文别名: (+)2,2'-亚甲基双(3α,8α-二氢-8H-茚并[1,2--d]噁唑;(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(-)-2,2'-亚甲基双(3α,8α-二氢-8H-茚并[1,2-d]噁唑;(+)-2,2 -亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑;(+)-2,2`-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚并[1,2-d]恶唑];(+)-2,2''-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并噁唑;(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并噁唑;(+)-2,2-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚并[1,2-d]恶唑];[3aR-[2(3′aR*,8′aS*),3′aβ,8′aβ]]-(+)-2,2′-亚甲基双[3a,8a-二氢-8H-茚并[1,2-]噁唑];[3aR-[2(3''aR*,8''aS*),3''aβ,8''aβ]]-(+)-2,2''--亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]噁唑];3-(2-甲氧基苯基)苯胺;甲基苯基氯化乙氧基化硅烷;(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-吲哚[1,2-d]恶唑];(3aR,3'aR,8aS,8'aS)-2,2'-亚甲基双[3a,8a-二氢-8H-茚并[1,2-d]恶唑];(+)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚并[1,2-D]恶唑];(+)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚并[1,2-D]噁唑];[3AR-[2(3′AR*,8′AS*),3′AΒ,8′AΒ]]-(+)-2,2′-亚甲基双[3A,8A-二氢-8H-茚并[1,2-]唑];[3AR-[2(3'AR*,8'AS*),3'AΒ,8'AΒ]]-(+)-2,2'--亚甲基双[3A,8A-二氢-8H-茚并[1,2-D]噁唑];(+)2,2'-亚甲基双(3Α,8Α-二氢-8H-茚并[1,2--D]噁唑;(+)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-吲哚[1,2-D]恶唑];(+)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚苯[1,2-D]并恶唑;(+)-2,2'-亚甲基双[(3AR,8AS)-3A,8A-二氢-8H-茚苯[1,2-D]并噁唑;(3AR,3'AR,8AS,8'AS)-2,2'-亚甲基双[3A,8A-二氢-8H-茚并[1,2-D]恶唑];[3AR-[2(3′AR*,8′AS*),3′AΒ,8′AΒ]]-(+)-2,2′-亚甲基双[3A,8A-二氢-8H-茚并[1,2-]噁唑]
英文名称: [3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole]
英文别名: Bis((3aR,8aS)-8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)methane;(+)-2,2'-Methylenebis[(3aR,8aS)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole];(-)-2,2'-METHYLENEBIS-[(3AR,8AS)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE] EP;[3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'-Methylenebis[3a,8a;8H-Indeno[1,2-d]oxazole,2,2'-methylenebis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-;([3-(methylsulfinyl)-3-(methylthio)cyclobutyl]oxymethyl)benzene;(3-(benzyloxy)-1-(methylsulfinyl)cyclobutyl)(methyl)sulfane;[3aR-[2(3′aR*,8′aS*),3′aβ,8′aβ]]-(+)-2,2′-Methylenebis[3a,8a;{(3aR,8aS)-bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazol-2-yl)}methane;1-methylsulfinyl-1-methylthio-3-benzyloxycyclobutane;2,2'-methylenebis[(3aR,8aS)-3a,8a-dihydro-8H-indeno[1,2-d]oxazole];AGN-PC-00LXRT;Benzene, [[3-(methylsulfinyl)-3-(methylthio)cyclobutoxy]methyl]-;CTK3H9483;(-)-2,2''-METHYLENEBIS-[(3AR,8AS)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE] EP;(3aR,3'aR,8aS,8'aS)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];[3ar-[2(3'ar*,8'as*),3'aβ,8'aβ]]-(+)-2,2'-methylenebis[3a,8a-dihydro-8h-indeno[1,2-]oxazole];[3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];[3aR-[2(3;(+)-2,2'-Methylenebis[(3AR,8AS)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole],98%;[3aR-[2(3'aR*,8'aS*),3'abeta,8'abeta]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 98%;[3aR-[2(3 inverted exclamation markaaR*,8 inverted exclamation markaaS*),3 inverted exclamation markaa;A,8 inverted exclamation markaa;A]]-(+)-2,2 inverted exclamation marka-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole];9455AA;J-;T71955;SCHEMBL12269622;(3aS,8bR)-2-[[(3aS,8bR)-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazol-2-yl]methyl]-4,8b-dihydro-3aH-indeno[1,2-d][1,3]oxazole;MFCD06797115;(3aR,8aS)-2-{[(3aR,8aS)-3aH,8H,8aH-indeno[1,2-d][1,3]oxazol-2-yl]methyl}-3aH,8H,8aH-indeno[1,2-d][1,3]oxazole;CS-W014505;NSC818112;(3aR,8aS,3a'R,8a'S)-2,2'-Methylenebis(8,8a-dihydro-3aH-indeno[1,2-d][1,3]oxazole);(+)-2,2/'-METHYLENEBIS[(3AR,8AS)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE];NSC-818112;8H-Indeno[1,2-d]oxazole, 2,2'-methylenebis[3a,8a-dihydro-, (3aR,3'aR,8aS,8'aS)-;A881149;AKOS015838876;180186-94-1;[3aR-[2(3'aR*,8'aS*),3'abeta,8'abeta]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98%;[3aR-[2(3'aR,8'aS),3'abeta,8'abeta]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-]oxazole];J-011510;DTXSID50361456;AS-75773
品牌: PERFEMIKER
CAS号: 180186-94-1
分子式: C21H18N2O2
分子量: 330.38
纯度: 98%
详细描述: 博飞美科的(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑,98%为亚胺配体 ,产品稳定,定制速度快,极大地方便了广大科研客户的使用需求。产品包装为1g。查询关键词:亚胺配体 ,180186-94-1,(+)-2,2'-亚甲基双[(3aR,8aS)-3a,8a-二氢-8H-茚苯[1,2-d]并恶唑,98%,[3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole],博飞美科,Perfemiker,上海,厂家现货。
暂无相关技术资料
暂无相关参考文献
搜索质检报告(COA)